Outcomes of transurethral resection of the prostate in unobstructed patients with concomitant detrusor underactivity.


Journal

Neurourology and urodynamics
ISSN: 1520-6777
Titre abrégé: Neurourol Urodyn
Pays: United States
ID NLM: 8303326

Informations de publication

Date de publication:
11 2020
Historique:
received: 26 05 2020
accepted: 19 07 2020
pubmed: 29 7 2020
medline: 26 2 2021
entrez: 29 7 2020
Statut: ppublish

Résumé

The aim of the study was to evaluate the transurethral resection of the prostate (TURP) outcomes of unobstructed patients with detrusor underactivity (DUA), comparing the surgical results between obstructed and unobstructed males with concomitant DUA, at midterm follow-up. This was an observational, prospective, comparative, nonrandomized study. Candidates to TURP underwent preoperative urodynamics (UD), with a diagnosis of DUA, were divided in two cohorts: Group A unobstructed men, group B males with bladder outlet obstruction (BOO). Males were evaluated yearly with uroflowmetry (UF), post-void residual (PVR), and bladder voiding efficiency (BVE), International Prostate Symptom Score (IPSS) questionnaire, visual analogic scale (VAS) for subjective assessment of the quality of life. The degree of the variation of maximum flow rate (Qmax), PVR, BVE, IPSS, VAS between baseline and follow-up (Δ) was evaluated. Patients in group A were 28 and in group B 23. Overall patient's mean ± SD age was 63.37 ± 12.41 years. Preoperative urodynamics characteristics: mean bladder contractility index (BCI) of 61.15 and 76.25 in group A and B, respectively; mean bladder outlet obstruction index (BOOI) of 17.25 and 50.15 in group A and group B, respectively. After surgery, overall patient group, group A, and group B showed a statistical improvement in IPSS score (P < .0001), Qmax (P < .0001), PVR (P < .0008), BVE (P < .03) and VAS (P < .0001). BOO had an important impact on the degree of improvement of Qmax and PVR/BVE, while had a poor influence on lower urinary tract symptoms amelioration. The most relevant outcomes were found when BOO was associated with DUA, which was not a contraindication to surgery.

Identifiants

pubmed: 32720738
doi: 10.1002/nau.24470
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2179-2185

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

© 2020 Wiley Periodicals LLC.

Références

Gravas S, Cornu JN, Gacci M, et al. Management of non-neurogenic male LUTS. European Urological Association EAU Guidelines, 2020.
Reich O, Gratzke C, Stief CG. Techniques and long-term results of surgical procedures for BPH. Eur Urol. 2006;49(6):970-978.
Madersbacher S, Marberger M. Is transurethral resection of the prostate still justified? BJU Int. 1999;83(3):227-236.
Madersbacher S, Lackner J, Brössner C, et al. Prostate Study Group of the Austrian Society of Urology. Eur Urol. 2005;47(4):499-504.
Lourenco T, Shaw M, Fraser C, MacLennan G, N'Dow J, Pickard R. The clinical effectiveness of transurethral incision of the prostate: a systematic review of randomised controlled trials. World J Urol. 2010;28(1):23-32.
Chapple CR, Osman NI, Birder L, et al. Terminology report from the International Continence Society (ICS) Working Group on Underactive Bladder (UAB). Neuourol Urodyn. 2018;37:1-4.
Rosier PFWM, Schaefer W, Lose G, et al. International Continence Society Good Urodynamic Practices and Terms 2016: urodynamics, uroflowmetry, cystometry, and pressure-flow study. Neurourol Urodyn. 2017;36(5):1243-1260.
Abrams P, Cardozo L, Fall M, et al. Standardisation sub-committee of the International Continence Society. The standardisation of terminology of lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Neurourol Urodyn. 2002;212(2):167-178.
Thomas AW, Cannon A, Bartlett E, Ellis-Jones J, Abrams P. The natural history of lower urinary tract dysfunction in men: the influence of detrusor underactivity on the outcomes after transurethral resection of the prostate with a minimum 10-year urodynamic follow-up. BJU Int. 2004;93:745-750.
Jeong SJ, Kim HJ, Lee YJ, et al. Prevalence and clinical features of detrusor underactivity among elderly with lower urinary tract symptoms: a comparison between men and women. Korean J Urol. 2012;53(5):342-348.
Javlé P, Jenkins SA, Machin DG, Parsons KF. Grading of benign prostatic obstruction can predict the outcome of transurethral prostatectomy. J Urol. 1998;160:1713-1717.
Gani J, Hennessy D. The underactive bladder: diagnosis and surgical treatment options. Transl Androl Urol. 2017;6(suppl 2):S186-S195.
Potts B, Belsante M, Peterson A, Le NB. Bladder outlet procedures are an effective treatment for patients with urodynamically- confirmed detrusor overactivity without bladder outlet obstruction. J Urol. 2016;195:e975.
Tanaka Y, Masumori N, Itoh N, Furuya S, Ogura H, Tsukamoto T. Is the short-term outcome of transurethral resection of the prostate affected by preoperative degree of bladder outlet obstruction, status of detrusor contractility or detrusor overactivity? Int J Urol. 2006;13:1398-1404.
Ou R, Pan C, Chen H, et al. Urodynamically diagnosed detrusor hypoconytractility: should transurethral resection of prostate be contraindicated? Int Urol Nephrol. 2012;44:35-39.
Masumori N, Furuya R, Tanaka Y, Furuya S, Ogura H, Tsukamoto T. The 12-year symptomatic outcome of transurethral resection of the prostate for patients with lower urinary tract symptoms suggestive of benign prostatic obstruction compared to the urodynamic findings before surgery. BJU Int. 2010;105:1429-1433.
Wada N, Kikuchi D, Tateoka J, et al. Long-term symptomatic outcome after transurethral resection of the prostate: a urodynamic-based assessment. Int J Urol. 2019;26(11):1071-1075.
Van Venrooij GE, van Melick HH, Boon TA. Comparison of outcomes of transurethral prostate resection in urodynamically obstructed versus selected urodynamically unobstructed or equivocal men. Urology. 2003;62:672-676.
Lee K-H, Kuo H-C. Recovery of voiding efficiency and bladder function in male patients with non-neurogenic detrusor underactivity after transurethral bladder outlet surgery. Urology. 2019;123:235-241.
Clement KD, Burden H, Warren K, Lapitan MC, Omar MI, Drake MJ. Invasive urodynamics studies for the management of lower urinary tract symptoms (LUTS) in men with voiding dysfunction. Cochrane Database Syst Rev. 2015;28(4):CD011179.
Kim M, Jeong CW, Oh SJ. Effect of preoperative urodynamic detrusor underactivity on transurethral surgery for benign prostatic hyperplasia: a systematic review and meta-analysis. J Urol. 2018;199:237-244.
Foster HE, Barry MJ, Gandhi MC, et al. Benign prostatic hyperplasia: surgical management of benign prostatic hyperplasia/lower urinary tract symptoms (2018, amended 2019). American Urological Association AUA Guidelines, 2020.
Abrams P. Bladder outlet obstruction index, bladder contractility index and bladder voiding efficiency: three simple indices to define bladder voiding function. BJU Int. 1999;84:14-15.
Seki N, Kai N, Seguchi H, Takei M, Yamaguchi A, Naito S. Predictives regarding outcome after transurethral resection for prostatic adenoma associated with detrusor underactivity. Urology. 2006;67:306-310.
Blaivas JG, Forde JC, Davila JL, et al. Surgical treatment of detrusor underactivity: a short term proof of concept study. Int Braz J Urol. 2017;43:540-548.
Gotoh M, Yoshikawa Y, Kondo AS, Kondo A, Ono Y, Ohshima S. Prognostic value of pressure-flow study in surgical treatment of benign prostatic obstruction. World J Urol. 1999;17(5):274-278.
Randomised Evaluation of Assessment Methods (UPSTREAM) for diagnosis and management of bladder outlet obstruction in men: study protocol for a randomised controlled trial. ClinicalTrials.govIdentifier:NCT02193451.
Oelke M, Rademakers KLJ, van Koeveringe GA FORCE Research Group, Maastricht & Hannover. Unravelling detrusor underactivity: development of a bladder outlet resistance-bladder contractility nomogram for adult male patients with lower urinary tract symptoms. Neurourol Urodyn. 2016;35(8):980-986.

Auteurs

Emanuele Rubilotta (E)

Department of Urology, A.O.U.I. Verona University, Italy.

Matteo Balzarro (M)

Department of Urology, A.O.U.I. Verona University, Italy.

Marilena Gubbiotti (M)

Department of Urology, San Donato Hospital, Arezzo, Italy.
Serafico Institute of Assisi, Research Centre "InVita", Assisi, Perugia, Italy.

Alessandro Antonelli (A)

Department of Urology, A.O.U.I. Verona University, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH